Balaxi Pharmaceuticals Limited (BALAXI.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 853.95M |
| Enterprise Value | 1.28B |
| P/E Ratio | 88.73 |
| PEG Ratio | -0.94 |
| Price/Sales Ratio | 0.09 |
| Price/Book Ratio | 0.52 |
| Enterprise/Revenue | 0.25 |
| Enterprise/EBITDA | 6.64 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.01 |
| Operating Margin | 0.03 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.01 |
Income Statement
| Revenue | 2.73B |
| Revenue/Share | 49.02 |
| Gross Profit | 1.14B |
| EBITDA | 74.46M |
| Net Income | 14.17M |
| Diluted EPS | 0.26 |
Balance Sheet
| Total Cash | 145.59M |
| Total Cash/Share | 2.61 |
| Total Debt | 576.49M |
| Total Debt/Equity | 0.23 |
| Current Ratio | 4.51 |
| Book Value Per Share | 44.71 |
Price History
| 52-Week Change | -53.64 |
| 52-Week High | 54.7 |
| 52-Week Low | 15.2 |
| Moving Average 50 Days | 25.53 |
| Moving Average 200 Days | 29.75 |
Statistics
| Average Volume | 88,077 |
| Shares Outstanding | 11.13M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 5:1 |
| Last Split Date | May 30, 2024 |
AD
